Arrakis Bio

Arrakis BioArrakis Bio
Arrakis Bio

Arrakis Bio

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Website
DR 2.32019Active5Cambridge, United States
Rate
Advertise here

About

Arrakis Bio bio-manufactures regenerative human biomaterials, starting with medical-grade human collagen. Their proprietary technology enables sustainable, scalable production of high-purity collagen for medical aesthetics, regenerative medicine, and biomedical research. Arrakis Bio aims to revolutionize the availability of these advanced biomaterials for a healthier and more beautiful future.
Frequently asked

What does Arrakis Bio do?

Arrakis Bio bio-manufactures regenerative human biomaterials, starting with medical-grade human collagen. Their proprietary technology enables sustainable, scalable production of high-purity collagen for medical aesthetics, regenerative medicine, and biomedical research. Arrakis Bio aims to revolutionize the availability of these advanced biomaterials for a healthier and more beautiful future.

What is Arrakis Bio's revenue?

StartupHub estimates Arrakis Bio's annual revenue at $869K (range $476K to $1.3M, 64% confidence), based on comparable companies in the sector.

Where is Arrakis Bio headquartered?

Arrakis Bio is headquartered in Cambridge, United States.

When was Arrakis Bio founded?

Arrakis Bio was founded in 2019.

What industry does Arrakis Bio operate in?

Arrakis Bio operates in Life Sciences, Agritech, Food, Biotech, MedTech, HealthTech.

How many employees does Arrakis Bio have?

Arrakis Bio has approximately 5 people on record.

HEADCOUNT
5
DOMAIN RATING
2.3
Comments

No comments yet. Be the first to share your take.